#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15776	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2137	732.7	0	.	n	.	0	C451T	SNP	451	451	C	692	692	T	914	T,C	463,394	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15776	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2137	732.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	841	C,T	796,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15776	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2137	732.7	0	HET	.	.	.	C207T	.	207	207	C	448	448	C	864	C,T	669,148	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28302	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3641	775.6	0	.	n	.	0	T695C	SNP	695	695	T	1063	1063	C	817	C	776	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28302	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3641	775.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	2006	2006	G	900	G,A	851,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28302	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3641	775.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2339	2339	C	960	C	903	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28302	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3641	775.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2413	2413	A	954	A	897	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28302	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3641	775.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2965	2965	C	899	C	843	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2040	folP	855	855	100.0	folP.l15.c4.ctg.1	1595	127.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1122	1124	AGC	226;226;226	A;G;C	217;219;216	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5216	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	150.4	1	SNP	p	S91F	1	.	.	271	273	TTC	615	617	TTC	162;163;163	T;T,C;C	148;148,1;150	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5216	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	150.4	1	SNP	p	G95N	0	.	.	283	285	GGC	627	629	GGC	162;161;161	G;G,A;C	153;148,1;149	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5216	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	150.4	1	SNP	p	D95G	1	.	.	283	285	GGC	627	629	GGC	162;161;161	G;G,A;C	153;148,1;149	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1628	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1368	118.8	1	SNP	p	G45D	0	.	.	133	135	GGC	473	475	GGC	182;179;180	G;G,C;C	174;169,1;171	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	764	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1135	67.3	0	.	n	.	0	A197.	DEL	197	197	A	716	716	A	180	A	172	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6110	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2962	205.7	1	SNP	p	D86N	0	.	.	256	258	GAC	552	554	GAC	251;254;256	G;A;C	235;235;243	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6110	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2962	205.7	1	SNP	p	R87W	0	.	.	259	261	CGT	555	557	CGT	257;257;257	C,T,A;G;T	240,1,1;240;236	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6110	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2962	205.7	1	SNP	p	S87R	1	.	.	259	261	CGT	555	557	CGT	257;257;257	C,T,A;G;T	240,1,1;240;236	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6110	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2962	205.7	1	SNP	p	R87I	0	.	.	259	261	CGT	555	557	CGT	257;257;257	C,T,A;G;T	240,1,1;240;236	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6110	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2962	205.7	1	SNP	p	S88P	0	.	.	262	264	TCC	558	560	TCC	257;259;260	T;C,A;C	243;244,1;247	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4270	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2720	156.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1487	1489	GGC	208;206;203	G;G;C	192;186;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1174	1176	GCC	215;214;215	G;C;C	203;204;203	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1177	1179	ATG	215;214;215	A;T;G	207;204;209	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1189	1191	ACC	214;215;215	A;C;C	209;209;211	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1189	1191	ACC	214;215;215	A;C;C	209;209;211	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1690	1692	ACC	228;231;235	A;C;C	202;211;216	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1744	1746	GCG	206;206;209	G;C;G	189;192;193	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1744	1746	GCG	206;206;209	G;C;G	189;192;193	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1867	1869	GGT	175;175;176	G;G;T	160;160;160	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1876	1878	AGC	174;174;174	A;G;C	157;158;155	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3958	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2300	171.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1894	1896	CCG	134;137;138	C,G;C;G	99,5;103;107	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6314	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3092	203.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1571	1573	CCG	225;225;224	C;C;G	200;209;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2512	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1803	138.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	154	C	144	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3202	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1735	184.0	1	SNP	p	G120K	1	.	.	358	360	AAG	686	688	AAG	238;240;242	A,G;A;G,A	228,1;234;229,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3202	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1735	184.0	1	SNP	p	N121D	0	.	.	361	363	AAC	689	691	AAC	241;240;239	A;A;C	233;233;231	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3202	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1735	184.0	1	SNP	p	A121N	1	.	.	361	363	AAC	689	691	AAC	241;240;239	A;A;C	233;233;231	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11354	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4886	231.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1208	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1042	115.3	1	SNP	p	V57M	1	.	.	169	171	ATG	505	507	ATG	258;257;253	A;T;G	245;242;240	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
